For press inquiries click here to contact us.
FierceBiotech
Arcus, Infinity team up on triple-combination studies in TNBC and ovarian cancer
FierceBiotech
Despite FDA hold, Epizyme’s tazemetostat posts positive interim data
FierceBiotech
GlaxoSmithKline’s head of dermatology joins JAK developer Aclaris
FierceBiotech
Mental health app maker Mindstrong raises $15M in series B
Xconomy
Jayson Dallas Leaves Ultragenyx for CEO Post at Aimmune
Endpoints
Novartis hands Regenxbio $100M in fast cash for vector tech
FierceBiotech
Editas commits $125M to Broad to secure source of genome editing inventions
FierceBiotech
Robert Zeldin to take post at Acceleron as its CMO retires
Xconomy
Alder BioPharmaceuticals Picks Juno’s Robert Azelby for CEO
Please see important disclaimers in the Terms section.
